C4 Therapeutics’ TORPEDO Platform Is Promising, But Its Valuation Remains Stretched
Motion Loop/iStock via Getty Images C4 Therapeutics, Inc. (NASDAQ:CCCC) pioneered targeted protein degradation with its TORPEDO platform to design molecules ...
Monday, January 6, 2025
Tag: TORPEDO
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.